Ocular Hypertension Treatment Study

The New York Eye & Ear Infirmary0 个研究点开始时间: 1994年2月最近更新: 2013年11月1日

适应症

试验速览

阶段: 不适用
状态: 已完成
发起方: The New York Eye & Ear Infirmary

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

The Ocular Hypertension Treatment Study is a multi-center clinical trial sponsored by the National Eye Institute, designed to determine the efficacy and safety of topically administered eye lowering medication

研究设计

研究类型: Observational

入排标准

年龄范围: 40 Years 至 80 Years（Adult, Older Adult）
性别: All
接受健康志愿者: 是

入选标准

•Qualifying IOP in at least one eye of each participant must be more than or equal 24 mmHg but less than or equal to 32 mm HG calculated from two separate consecutive determination taken at least 2 hours, but not greater than 12 weeks apart.
•Normal and reliable 30-2 Humphrey Visual Fields in both eyes.
•Normal Optic disc in both eyes on clinical examinations and stereoscopic photographs as determined by the Optic Disc Reading Center.

排除标准

•Visual acuity worse than 20/40 in either eye on qualifying exam.
•Previous intraocular surgery: laser trabeculoplasty, laser iridotomy, filtering surgery, combined cataract extraction/filtering procedures, penetrating keratoplasty and retinal detachment repair.

研究者

发起方

The New York Eye & Ear Infirmary

申办方类型

Other

相似试验

已完成

2 期

Study of an Investigational Product, QLS-111, Provided as an Eyedrop, for Treatment of Normal Tension Glaucoma (NTG)Normal Tension Glaucoma (NTG)Low-Tension Glaucoma, BilateralLow-Tension Glaucoma, Unspecified EyeGlaucoma

NCT06030193Qlaris Bio, Inc.37

Unknown

3 期

A Study of Efficacy and Safety of PHP-201 in Patients With Primary Open Angle Glaucoma or Ocular HypertensionPrimary Open Angle GlaucomaOcular Hypertension

NCT04863365pH Pharma110

已完成

3 期

Ocular Hypertension Treatment Study (OHTS)GlaucomaOcular Hypertension

NCT00000125Washington University School of Medicine1,636

已完成

2 期

A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 DaysOpen Angle GlaucomaOcular Hypertension

NCT01789736Aerie Pharmaceuticals234

已完成

2 期

Qlaris Study of QLS-111 in Combination With a PGA for OAG and/or OHT PatientsOpen-angle Glaucoma (OAG)Ocular Hypertension (OHT)Glaucoma

NCT06249152Qlaris Bio, Inc.36